IDSA : View All Statements on U.S. Resistance Efforts

11/15/2012

IDSA Statement presented at the Interagency Task Force on Antimicrobial Resistance (ITFAR) Meeting

IDSA statement on the current U.S. response to antimicrobial resistance, presented at the ITFAR Meeting, November 15, 2012.

11/15/2011

IDSA Comments on the AR Action Plan (PDF)

IDSA statement on the Public Health Action Plan to Combat Antimicrobial Resistance at the Interagency Task Force on Antimicrobial Resistance (ITFAR) meeting.

04/15/2011

IDSA Testimony on Fiscal Year 2012 Funding for Department of Health and Human Services (PDF)

IDSA supports strengthened funding for antimicrobial resistance efforts in its statement submitted to the House Appropriations Committee covering the Centers for Disease Control and Prevention, National Institutes of Health, and the Biomedical Advanced Research and Development Authority.

04/07/2011

Combating Antimicrobial Resistance: Policy Recommendations to Save Lives

IDSA issued a comprehensive set of recommendations in a policy paper published in a special supplement of Clinical Infectious Diseases. See also the one-page summary (PDF), IDSA's letter to President Obama (PDF), and presentation slides from our congressional briefing.

03/19/2010

IDSA Urges Increased Funding for FDA Antimicrobial Resistance Activities (PDF)

In testimony to the House Agriculture Appropriations Subcommittee, IDSA urged a $20 million increase in antimicrobial resistance and antibacterial drug review programs at the Food and Drug Administration, as well as an increase for the new regulatory science initiative.

12/04/2009

New US/EU Transatlantic Task Force on Antimicrobial Resistance and IDSA's 10x'20 Initiative: Two's Path Forward

Robert Guidos, JD, IDSA, VP, Public Policy & Government Relations, outlines IDSA's position in an invited guest column of the Center for Global Development's newsletter.

04/28/2008

IDSA Testimony on Antimicrobial Resistance at FDA Part 15 Hearing (PDF)

IDSA provided testimony at an FDA hearing on antimicrobial resistance and made twelve recommendations on appropriate FDA actions to help lead federal efforts to combat this growing problem.

01/15/2008

The Epidemic of Antimicrobial Resistant Infections: A Call to Action for the Medical Community from the Infectious Diseases Society of America (PDF)

Spellberg et al., Clinical Infectious Diseases vol. 46 no. 2 January 15, 2008 155-164.

04/24/2006

Principles and Strategies to Limit Impact of Antimicrobial Resistance (PDF)

IDSA calls attention to the seriousness and rapidly increasing rate of antimicrobial resistance, and delineates two major principles to limit the impact of antimicrobial resistance: good antimicrobial stewardship and control/prevention.